Mendel Capital Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
ECSS
ATO
Mendel Capital Management's ABBV Position: Q2 2026 in Review
Mendel Capital Management increased its AbbVie (ABBV) stake by 0.13% in Q2 2026, buying an estimated $2.15K and bringing the position to 7,949 shares worth $2M. The position accounts for 0.9% of the portfolio, ranked #24.
Mendel Capital Management first reported a position in ABBV in Q4 2021 and has held it in 18 quarters since. 2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Mendel Capital Management held 7,949 shares of AbbVie worth $2M as of Q2 2026.
- Mendel Capital Management bought 10 AbbVie shares in Q2 2026, an estimated $2.15K.
- AbbVie made up 0.9% of Mendel Capital Management's portfolio in Q2 2026, its #24 holding.
- Mendel Capital Management first reported a position in AbbVie in Q4 2021 and has held it in 18 quarters since.
- 2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Mendel Capital Management's 13F filing for Q2 2026, filed 21 Jul 2026.